
Opinion|Videos|July 31, 2024
Important NSCLC Biomarkers
Fred R. Hirsch, MD, PhD, leads a discussion with his Mount Sinai colleagues about important biomarkers found in non-small cell lung cancer, including those that provide predictive and prognostic information.
Advertisement
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
Frontline Immunotherapy Improves OS Vs BRAF/MEK Inhibitors in BRAF+ NSCLC
5